Published 2005 | Version v1
Publication

Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.

Additional details

Created:
April 14, 2023
Modified:
December 1, 2023